| Features: |
| Metronomic chemotherapy refers to the therapeutic strategy of administering chemotherapeutic drugs at relatively low, minimally toxic doses on a frequent or continuous schedule without extended rest periods. This dosing regimen contrasts with traditional maximum tolerated dose (MTD) chemotherapy, which involves high doses given intermittently with breaks to allow patient recovery. -The drugs are given in lower doses and more frequently (often daily or multiple times a week) -Aims to consistently impair tumor growth mechanisms and potentially minimize the chance for cancer cells to recover -Aims to consistently impair tumor growth mechanisms and potentially minimize the chance for cancer cells to recover -With a lower dose intensity, patients often experience fewer and less severe side effects |
| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 2488- | metroC, | Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma |
| - | in-vitro, | HCC, | HUH7 | - | in-vivo, | HCC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:327 Target#:1114 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid